ProstaLund Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Public

  • Employees
  • 10


  • Stock Symbol
  • PLUN

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.09
  • (As of Friday Closing)

ProstaLund General Information


Prostalund AB is a medical technology company engaged in development of products and treatments in urology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
Corporate Office
  • Scheelevagen 19
  • 223 63 Lund
  • Sweden
+46 046-12 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProstaLund Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.09 $0.09 $0.09 - $0.39 $7.02M 76.6M 81.6K -$0.02

ProstaLund Financials Summary

In Thousands,
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 10,530 10,530 20,566 21,709
Revenue 2,089 2,089 1,716 1,988
EBITDA (1,560) (1,560) (1,052) (877)
Net Income (1,600) (1,600) (1,094) (918)
Total Assets 6,555 6,555 4,893 4,805
Total Debt 133 133 166 22
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ProstaLund Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ProstaLund‘s full profile, request access.

Request a free trial

ProstaLund Executive Team (7)

Name Title Board Seat Contact Info
Anders Kristensson Chief Executive Officer
Erika Carlsson Chief Operating Officer
Göran Dybner Marketing & Sales Director
You’re viewing 3 of 7 executive team members. Get the full list »

ProstaLund Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProstaLund Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nordisk Medicin & Teknik 05-Sep-2014 0000000000 00000 Pharmaceuticals
To view ProstaLund’s complete acquisitions history, request access »

ProstaLund Subsidiaries (1)

Company Name Industry Location Founded
Nordisk Medicin & Teknik Pharmaceuticals Boras, Sweden 0000
To view ProstaLund’s complete subsidiaries history, request access »

ProstaLund FAQs

  • When was ProstaLund founded?

    ProstaLund was founded in 1991.

  • Who is the founder of ProstaLund?

    Magnus Bolmsjö is the founder of ProstaLund.

  • Who is the CEO of ProstaLund?

    Anders Kristensson is the CEO of ProstaLund.

  • Where is ProstaLund headquartered?

    ProstaLund is headquartered in Lund, Sweden.

  • What is the size of ProstaLund?

    ProstaLund has 10 total employees.

  • What industry is ProstaLund in?

    ProstaLund’s primary industry is Drug Discovery.

  • Is ProstaLund a private or public company?

    ProstaLund is a Public company.

  • What is ProstaLund’s stock symbol?

    The ticker symbol for ProstaLund is PLUN.

  • What is the current stock price of ProstaLund?

    As of 19-Apr-2024 the stock price of ProstaLund is $0.09.

  • What is the current market cap of ProstaLund?

    The current market capitalization of ProstaLund is $7.02M.

  • What is ProstaLund’s current revenue?

    The trailing twelve month revenue for ProstaLund is $2.09M.

  • What is ProstaLund’s annual earnings per share (EPS)?

    ProstaLund’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »